carbostyril and Chronic Hepatitis C
carbostyril has been researched along with Chronic Hepatitis C in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Appleman, JR; Crowley, CA; Freddo, JL; Mallalieu, NL; Rahimy, MH; Smith, PF | 1 |
Brunda, M; Chu, T; Elston, R; Gane, EJ; George, J; Glavini, K; Hammond, JM; Jensen, DM; Le Pogam, S; Nájera, I; Passe, S; Piekarska, A; Rodriguez, I; Zeuzem, S | 1 |
Tedaldi, EM | 1 |
Hirakata, R; Migita, S; Miyake, K; Nomura, H; Okamoto, O; Shiraishi, G | 1 |
Reviews
1 review(s) available for carbostyril and Chronic Hepatitis C
Article | Year |
---|---|
Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.
Topics: Anti-Retroviral Agents; Antiviral Agents; Comorbidity; Hepatitis C, Chronic; HIV Infections; Humans; Pyrimidine Nucleosides; Pyrrolidinones; Quinolones; Raltegravir Potassium; Substance Abuse, Intravenous | 2008 |
Trials
3 trial(s) available for carbostyril and Chronic Hepatitis C
Article | Year |
---|---|
Pharmacokinetics and pharmacodynamics of setrobuvir, an orally administered hepatitis C virus non-nucleoside analogue inhibitor.
Topics: Adolescent; Adult; Antiviral Agents; Benzothiadiazines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Quinolones; Young Adult | 2014 |
Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study.
Topics: Adult; Antiviral Agents; Australia; Benzothiadiazines; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Europe; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Isoindoles; Lactams; Lactams, Macrocyclic; Male; Middle Aged; New Zealand; Phenotype; Proline; Quinolones; Remission Induction; Ribavirin; RNA, Viral; Sulfonamides; Time Factors; Treatment Outcome; United States; Viral Load | 2016 |
Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery.
Topics: Adult; Aged; Alanine; Carcinoma, Hepatocellular; Embolization, Therapeutic; Esophageal and Gastric Varices; Female; Gastric Mucosa; Hepatic Artery; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Quinolones; Stomach Ulcer | 1999 |